Michael J. DeBiasi - Director at RVL Pharmaceuticals plc

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Michael J. DeBiasi since 26 Aug 2025

Reported holdings for Michael J. DeBiasi in RVL Pharmaceuticals plc

Form 4 holding Director

RVL Pharmaceuticals plc

Security class
Ordinary Shares
Shares / value
40,000
Estimated value
$1,248
Report date
05 Jul 2023
Price
$0.0312
Ownership
Direct

Transaction history for Michael J. DeBiasi in RVL Pharmaceuticals plc

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .